Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Upper gastrointestinal tract involvement of Crohn disease: clinical implications in children and adolescents

  • Kim, Eun Sil (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Mi Jin (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2021.05.17
  • Accepted : 2021.08.07
  • Published : 2022.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Crohn disease (CD) is a multifactorial inflammatory disorder that can affect all segments of the gastrointestinal (GI) tract but typically involves the ileum and/or colon. To assess patient prognosis and choose appropriate treatment, it is necessary to accurately evaluate the factors influencing poor outcomes, including disease phenotype. Pediatric CD involving the upper GI (UGI) tract has become increasingly recognized with the introduction of routine upper endoscopy with biopsies for all patients and the increased availability of accurate small bowel evaluations. Most clinical manifestations are mild and nonspecific; however, UGI involvement should not be overlooked since it can cause serious complications. Although controversy persists about the definition of upper GI involvement, aphthoid ulcers, longitudinal ulcers, a bamboo joint-like appearance, stenosis, and fistula are endoscopic findings suggestive of CD. In addition, the primary histological findings, such as focally enhanced gastritis and noncaseating granulomas, are highly suggestive of CD. The association between UGI involvement and poor prognosis of CD remains controversial. However, the unstandardized definition and absence of a validated tool for evaluating disease severity complicate the objective assessment of UGI involvement in CD. Therefore, more prospective studies are needed to provide further insight into the standardized assessment of UGI involvement and long-term prognosis of CD. Our review summarizes the findings to date in the literature as well as UGI involvement in CD and its clinical implications.

Keywords

References

  1. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012;380:1590-605. https://doi.org/10.1016/S0140-6736(12)60026-9
  2. Ghione S, Sarter H, Fumery M, Armengol-Debeir L, Savoye G, Ley D, et al. Dramatic increase in incidence of ulcerative colitis and Crohn's disease (1988-2011): a population-based study of French adolescents. Am J Gastroenterol 2018;113:265-72. https://doi.org/10.1038/ajg.2017.228
  3. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017;390:2769-78. https://doi.org/10.1016/S0140-6736(17)32448-0
  4. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 201;17:423-39. https://doi.org/10.1002/ibd.21349
  5. Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, et al. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig Dis Sci 2010;55:1989-95. https://doi.org/10.1007/s10620-009-0963-5
  6. van Rheenen PF, Aloi M, Assa A, Bronsky J, Escher JC, Fagerberg UL, et al. The medical management of paediatric Crohn's disease: an ECCO-ESPGHAN guideline update J Crohns Colitis 2020 Oct 7;jjaa161. https://doi.org/10.1093/ecco-jcc/jjaa161. [Epub].
  7. Cosnes J, Bourrier A, Nion-Larmurier I, Sokol H, Beaugerie L, Seksik P. Factors affecting outcomes in Crohn's disease over 15 years. Gut 2012;61:1140-5. https://doi.org/10.1136/gutjnl-2011-301971
  8. Zallot C, Peyrin-Biroulet L. Clinical risk factors for complicated disease: how reliable are they? Dig Dis 2012;30 Suppl 3:67-72. https://doi.org/10.1159/000342608
  9. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53. https://doi.org/10.1136/gut.2005.082909
  10. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. https://doi.org/10.1002/ibd.21493
  11. Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014;58:795-806. https://doi.org/10.1097/mpg.0000000000000239
  12. van Hogezand RA, Witte AM, Veenendaal RA, Wagtmans MJ, Lamers CB. Proximal Crohn's disease: review of the clinicopathologic features and therapy. Inflamm Bowel Dis 2001;7:328-37. https://doi.org/10.1097/00054725-200111000-00010
  13. Horjus Talabur Horje CS, Meijer J, Rovers L, van Lochem EG, Groenen MJ, Wahab PJ. Prevalence of upper gastrointestinal lesions at primary diagnosis in adults with inflammatory bowel disease. Inflamm Bowel Dis 2016;22:1896-901. https://doi.org/10.1097/MIB.0000000000000786
  14. Reynolds HL Jr, Stellato TA. Crohn's disease of the foregut. Surg Clin North Am 2001;81:117-35, viii. https://doi.org/10.1016/S0039-6109(05)70276-0
  15. Crocco S, Martelossi S, Giurici N, Villanacci V, Ventura A. Upper gastrointestinal involvement in paediatric onset Crohn's disease: prevalence and clinical implications. J Crohns Colitis 2012;6:51-5. https://doi.org/10.1016/j.crohns.2011.06.013
  16. Lazarev M, Huang C, Bitton A, Cho JH, Duerr RH, McGovern DP, et al. Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol 2013;108:106-12. https://doi.org/10.1038/ajg.2012.389
  17. Rowland M, Fleming P, Bourke B. Looking in the mouth for Crohn's disease. Inflamm Bowel Dis 2010;16:332-7. https://doi.org/10.1002/ibd.20983
  18. Laube R, Liu K, Schifter M, Yang JL, Suen MK, Leong RW. Oral and upper gastrointestinal Crohn's disease. J Gastroenterol Hepatol 2018;33:355-64. https://doi.org/10.1111/jgh.13866
  19. Nugent FW, Roy MA. Duodenal Crohn's disease: an analysis of 89 cases. Am J Gastroenterol 1989;84:249-54.
  20. Yamamoto T, Allan RN, Keighley MR. An audit of gastroduodenal Crohn disease: clinicopathologic features and management. Scand J Gastroenterol 1999;34:1019-24. https://doi.org/10.1080/003655299750025138
  21. Kim ES, Park JH, Choe YH, Kim MJ. Pediatric Crohn's disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature. Intest Res 2021;19:472-7. https://doi.org/10.5217/ir.2020.00072
  22. Franklin RH, Taylor S. Nonspecific granulomatous (regional) esophagitis. J Thorac Surg 1950;19:292-7. https://doi.org/10.1016/S0096-5588(20)31767-0
  23. Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn's disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol 2012;10:208. https://doi.org/10.1186/1477-7819-10-208
  24. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease. Am J Gastroenterol 1997;92:1467-71.
  25. Mottet C, Juillerat P, Pittet V, Gonvers JJ, Michetti P, Vader JP, et al. Upper gastrointestinal Crohn's disease. Digestion 2007;76:136-40. https://doi.org/10.1159/000111028
  26. Cooper MB, Winawer SJ. Gastroduodenal Crohn's disease presenting as biliary colic. Am J Gastroenterol 1975;63:481-5.
  27. Ramos LR, Sachar DB, DiMaio CJ, Colombel JF, Torres J. Inflammatory Bowel disease and pancreatitis: a review. J Crohns Colitis 2016;10:95-104. https://doi.org/10.1093/ecco-jcc/jjv153
  28. Eisner TD, Goldman IS, McKinley MJ. Crohn's disease and pancreatitis. Am J Gastroenterol 1993;88:583-6.
  29. Cooke WT, Swan CH. Diffuse jejuno-ileitis of Crohn's disease. Q J Med 1974;43:583-601.
  30. Kim ES, Kwon Y, Choe YH, Kim MJ. Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients. Sci Rep 2020;10:19032. https://doi.org/10.1038/s41598-020-75938-1
  31. Kamboj AK, Kane SV, Leggett CL. Crohn's disease of the esophagus. Clin Gastroenterol Hepatol 2020 Oct 17;S1542-3565(20)31445-2. https://doi.org/10.1016/j.cgh.2020.10.032. [Epub].
  32. Decker GA, Loftus EV Jr, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn's disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis 2001;7:113-9. https://doi.org/10.1097/00054725-200105000-00006
  33. Naranjo-Rodriguez A, Solorzano-Peck G, Lopez-Rubio F, Calanas-Continente A, Galvez-Calderon C, Gonzalez-Galilea A, et al. Isolated oesophageal involvement of Crohn's disease. Eur J Gastroenterol Hepatol 2003;15:1123-6. https://doi.org/10.1097/00042737-200310000-00010
  34. De Felice KM, Katzka DA, Raffals LE. Crohn's disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis 2015;21:2106-13. https://doi.org/10.1097/MIB.0000000000000469
  35. Wespi SP, Frei R, Sulz MC. A very rare cause of a relapsing paraoesophageal abscess. Case Rep Gastroenterol 2016;10:132-8. https://doi.org/10.1159/000445183
  36. Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L, et al. Upper gastrointestinal tract involvement in Crohn's disease: frequency, risk factors, and disease course. J Crohns Colitis 2018;12:1399-409. https://doi.org/10.1093/ecco-jcc/jjy121
  37. Rutgeerts P, Onette E, Vantrappen G, Geboes K, Broeckaert L, Talloen L. Crohn's disease of the stomach and duodenum: A clinical study with emphasis on the value of endoscopy and endoscopic biopsies. Endoscopy 1980;12:288-94. https://doi.org/10.1055/s-2007-1021762
  38. Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn's disease patients. Pathol Res Pract 1985;179:377-87. https://doi.org/10.1016/s0344-0338(85)80147-3
  39. Danzi JT, Farmer RG, Sullivan BH Jr, Rankin GB. Endoscopic features of gastroduodenal Crohn's disease. Gastroenterology 1976;70:9-13. https://doi.org/10.1016/s0016-5085(76)80395-2
  40. Yokota K, Saito Y, Einami K, Ayabe T, Shibata Y, Tanabe H, et al. A bamboo joint-like appearance of the gastric body and cardia: possible association with Crohn's disease. Gastrointest Endosc 1997;46:268-72. https://doi.org/10.1016/S0016-5107(97)70100-7
  41. Fujiya M, Sakatani A, Dokoshi T, Tanaka K, Ando K, Ueno N, et al. A bamboo joint-like appearance is a characteristic finding in the upper gastrointestinal tract of Crohn's disease patients: a case-control study. Medicine (Baltimore) 2015;94:e1500. https://doi.org/10.1097/MD.0000000000001500
  42. Hokama A, Nakamura M, Ihama Y, Chinen H, Kishimoto K, Kinjo F, et al. Notched sign and bamboo-joint-like appearance in duodenal Crohn's disease. Endoscopy 2008;40 Suppl 2:E151. https://doi.org/10.1055/s-2007-995774
  43. Kovacs M, Muller KE, Arato A, Lakatos PL, Kovacs JB, Varkonyi A, et al. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry. J Crohns Colitis 2012;6:86-94. https://doi.org/10.1016/j.crohns.2011.07.008
  44. Turner D, Griffiths AM. Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis. Curr Gastroenterol Rep 2007;9:475-8. https://doi.org/10.1007/s11894-007-0062-8
  45. Sakuraba A, Iwao Y, Matsuoka K, Naganuma M, Ogata H, Kanai T, et al. Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn's disease. Biomed Res Int 2014;2014:610767. https://doi.org/10.1155/2014/610767
  46. Lenaerts C, Roy CC, Vaillancourt M, Weber AM, Morin CL, Seidman E. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics 1989;83:777-81. https://doi.org/10.1542/peds.83.5.777
  47. Cameron DJ. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study. J Gastroenterol Hepatol 1991;6:355-8. https://doi.org/10.1111/j.1440-1746.1991.tb00870.x
  48. Carbo AI, Reddy T, Gates T, Vesa T, Thomas J, Gonzalez E. The most characteristic lesions and radiologic signs of Crohn disease of the small bowel: air enteroclysis, MDCT, endoscopy, and pathology. Abdom Imaging 2014;39:215-34. https://doi.org/10.1007/s00261-013-0036-2
  49. de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, et al. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013;19:378-85. https://doi.org/10.1002/ibd.23008
  50. Ledder O, Church P, Cytter-Kuint R, Martinez-Leon M, Sladek M, Coppenrath E, et al. A Simple Endoscopic Score Modified for the Upper Gastrointestinal Tract in Crohn's Disease [UGI-SES-CD]: a report from the ImageKids study. J Crohns Colitis 2018;12:1073-8.
  51. Ebach DR, Vanderheyden AD, Ellison JM, Jensen CS. Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn's disease. Inflamm Bowel Dis 2011;17:45-9. https://doi.org/10.1002/ibd.21347
  52. Castellaneta SP, Afzal NA, Greenberg M, Deere H, Davies S, Murch SH, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004;39:257-61. https://doi.org/10.1097/00005176-200409000-00006
  53. Hummel TZ, ten Kate FJ, Reitsma JB, Benninga MA, Kindermann A. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J Pediatr Gastroenterol Nutr 2012;54:753-7. https://doi.org/10.1097/MPG.0b013e318243e3e3
  54. Sutton LM, Heintz DD, Patel AS, Weinberg AG. Lymphocytic esophagitis in children. Inflamm Bowel Dis 2014;20:1324-8. https://doi.org/10.1097/MIB.0000000000000100
  55. Oberhuber G, Puspok A, Oesterreicher C, Novacek G, Zauner C, Burghuber M, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997;112:698-706. https://doi.org/10.1053/gast.1997.v112.pm9041230
  56. Hardee S, Alper A, Pashankar DS, Morotti RA. Histopathology of duodenal mucosal lesions in pediatric patients with inflammatory bowel disease: statistical analysis to identify distinctive features. Pediatr Dev Pathol 201;17:450-4. https://doi.org/10.2350/14-07-1529-OA.1
  57. Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn's disease. Virchows Arch 1998;432:49-52. https://doi.org/10.1007/s004280050133
  58. Parente F, Cucino C, Bollani S, Imbesi V, Maconi G, Bonetto S, et al. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am J Gastroenterol 2000;95:705-11. https://doi.org/10.1016/S0002-9270(99)00910-7
  59. Roka K, Roma E, Stefanaki K, Panayotou I, Kopsidas G, Chouliaras G. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases. J Crohns Colitis 2013;7:797-802. https://doi.org/10.1016/j.crohns.2012.11.003
  60. McHugh JB, Gopal P, Greenson JK. The clinical significance of focally enhanced gastritis in children. Am J Surg Pathol 2013;37:295-9. https://doi.org/10.1097/PAS.0b013e31826b2a94
  61. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009;24:1587-600. https://doi.org/10.1111/j.1440-1746.2009.05982.x
  62. Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:469-76. https://doi.org/10.1111/j.1365-2036.2011.04969.x
  63. Wu XW, Ji HZ, Yang MF, Wu L, Wang FY. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol 2015;21:4750-6. https://doi.org/10.3748/wjg.v21.i15.4750
  64. Song MJ, Park DI, Hwang SJ, Kim ER, Kim YH, Jang BI, et al. The prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease, a multicenter study. Korean J Gastroenterol 2009;53:341-7. (Korean). https://doi.org/10.4166/kjg.2009.53.6.341
  65. Bartels LE, Jepsen P, Christensen LA, Gerdes LU, Vilstrup H, Dahlerup JF. Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease. J Crohns Colitis 2016;10:443-8. https://doi.org/10.1093/ecco-jcc/jjv229
  66. Wagtmans MJ, Witte AM, Taylor DR, Biemond I, Veenendaal RA, Verspaget HW, et al. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol 1997;32:712-8. https://doi.org/10.3109/00365529708996523
  67. Park JH, Nam HN, Lee JH, Hong J, Yi DY, Ryoo E, et al. Characteristics of upper gastrointestinal tract involvement in Korean Pediatric Crohn's disease: a multicenter study. Pediatr Gastroenterol Hepatol Nutr 2017;20:227-35. https://doi.org/10.5223/pghn.2017.20.4.227
  68. Birimberg-Schwartz L, Zucker DM, Akriv A, Cucchiara S, Cameron FL, Wilson DC, et al. Development and validation of diagnostic criteria for IBD subtypes including IBD-unclassified in children: a multicentre study from the pediatric IBD Porto Group of ESPGHAN. J Crohns Colitis 2017;11:1078-84.
  69. Ashton JJ, Coelho T, Ennis S, Vadgama B, Batra A, Afzal NA, et al. Endoscopic versus histological disease extent at presentation of paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2016;62:246-51. https://doi.org/10.1097/MPG.0000000000001032
  70. Colombel JF, D'haens G, Lee WJ, Petersson J, Panaccione R. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis 2020;14:254-66. https://doi.org/10.1093/ecco-jcc/jjz131
  71. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50. https://doi.org/10.1097/00054725-200207000-00002
  72. Kim HJ, Oh SH, Kim DY, Lee HS, Park SH, Yang SK, et al. Clinical characteristics and long-term outcomes of paediatric Crohn's disease: a single-centre experience. J Crohns Colitis 2017;11:157-64. https://doi.org/10.1093/ecco-jcc/jjw146
  73. Sun XW, Wei J, Yang Z, Jin XX, Wan HJ, Yuan BS, et al. Clinical features and prognosis of Crohn's disease with upper gastrointestinal tract phenotype in Chinese patients. Dig Dis Sci 2019;64:3291-9. https://doi.org/10.1007/s10620-019-05651-1
  74. Moon JS, Lee JL, Yu CS, Lim SB, Park IJ, Yoon YS, et al. Clinical characteristics and postoperative outcomes of patients presenting with upper gastrointestinal tract Crohn disease. Ann Coloproctol 2020;36:243-8. https://doi.org/10.3393/ac.2019.10.16.1
  75. Kim OZ, Han DS, Park CH, Eun CS, Kim YS, Kim YH, et al. The clinical characteristics and prognosis of Crohn's disease in Korean patients showing proximal small bowel involvement: results from the CONNECT study. Gut Liver 2018;12:67-72. https://doi.org/10.5009/gnl16500
  76. Chow DK, Sung JJ, Wu JC, Tsoi KK, Leong RW, Chan FK. Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization. Inflamm Bowel Dis 2009;15:551-7. https://doi.org/10.1002/ibd.20804
  77. Park SK, Yang SK, Park SH, Park SH, Kim JW, Yang DH, et al. Long-term prognosis of the jejunal involvement of Crohn's disease. J Clin Gastroenterol 2013;47:400-8. https://doi.org/10.1097/mcg.0b013e3182705f9e
  78. Mao R, Tang RH, Qiu Y, Chen BL, Guo J, Zhang SH, et al. Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype? Therap Adv Gastroenterol 2018;11:1756284818777938. https://doi.org/10.1177/1756284818777938